MMCAP International’s Liminatus Pharma Warrants LIMNW Stock Holding History

MMCAP International’s Portfolio LIMNW Stock Details LIMNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.2K	Hold	111,745	–	–	﹤0.01%	309
2026 Q2	$8.38K	Hold	111,745	–	–	﹤0.01%	286
2026 Q1	$4.47K	Hold	111,745	–	–	﹤0.01%	238
2025 Q4	$3.91K	Hold	111,745	–	–	﹤0.01%	203
2025 Q3	$16.5K	Hold	111,745	–	–	﹤0.01%	150
2025 Q2	$26.8K	Buy	+111,745	New	+$22K	﹤0.01%	114

Other funds holding LIMNW

Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $200M AUM 6.35% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Flow Traders U.S. New York $4.12B AUM 34.04% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $14.8M AUM 14.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

MMCAP International's LIMNW Position: Q3 2026 in Review

MMCAP International held its Liminatus Pharma Warrants (LIMNW) position steady in Q3 2026 at 111,745 shares worth $6.2K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

MMCAP International first reported a position in LIMNW in Q2 2025 and has held it in 6 quarters since. The position peaked at $26.8K in Q2 2025. 9 funds tracked by Wall St. Rank hold LIMNW as of Q3 2026.

MMCAP International held 111,745 shares of Liminatus Pharma Warrants worth $6.2K as of Q3 2026.
MMCAP International left its Liminatus Pharma Warrants share count unchanged in Q3 2026.
Liminatus Pharma Warrants made up ﹤0.01% of MMCAP International's portfolio in Q3 2026, its #309 holding.
MMCAP International first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 6 quarters since.
MMCAP International's Liminatus Pharma Warrants position peaked at $26.8K in Q2 2025.
9 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q3 2026.

Based on MMCAP International's 13F filing for Q3 2026, filed 12 Nov 2026.